← Back to Search

Behavioural Intervention

A cell phone tips for Diabetes

N/A
Waitlist Available
Led By Amanda Bell, MD
Research Sponsored by Walter Reed Army Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 0, week 12, week 26, week 38, week 52
Awards & highlights

Study Summary

The purpose of the study is to determine whether having a video cell phone that gives daily reminders over a 6-month period to check blood surgery and take your diabetes medications can improve your diabetes control during that time and if that benefit lasts for up to 1 year.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 0, week 12, week 26, week 38, week 52
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 0, week 12, week 26, week 38, week 52 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The primary endpoint will be improvement of glycemic control as measured by glycosylated hemoglobin (A1c).
Secondary outcome measures
To compare mean blood glucose levels,the number of hypo- and hyperglycemic events,the duration of time spent in target blood glucose range,the perceived level of diabetes-related stress and the perceived effect of diabetes on quality of life.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: A cell phone tipsExperimental Treatment1 Intervention
This group will receive a cell phone and cell phone service for 1 year. This group will receive a daily video reminders and tips for the first 6 months of the study. For the second 6 months this group will be seen by their providers at least every 3 months, but the video reminders and and tips will no longer be sent. The group will be instructed on how to use the cell phone. The group will be asked to check blood sugar on a schedule determined by their providers. The group will have blood sugars downloaded from from the glucometer by their providers at every visit and reviewed. The group will have the A1c measured. Also it will have this test repeated about every 3 months. They will continue to have monitored their A1c at 24, 38 and 52 weeks of the study.
Group II: B no cell phone tipsActive Control1 Intervention
This group will receive a cell phone and cell phone service for 1 year. For the second 6 months this group will be seen by their providers at least every 3 months. The group will be instructed on how to use the cell phone.The group will be asked to check blood sugar on a schedule determined by their provider. The groups will have blood sugars downloaded from from the glucometer by their provider at every visit and reviewed. The group will have A1c measured. Also it will have this test repeated about every 3 months. They will continue to have monitored their A1c at 24, 38 and 52 weeks of the study.

Find a Location

Who is running the clinical trial?

Affinity Networks, Inc.Industry Sponsor
Walter Reed Army Medical CenterLead Sponsor
69 Previous Clinical Trials
20,769 Total Patients Enrolled
Amanda Bell, MDPrincipal InvestigatorWRAMC

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~10 spots leftby Apr 2025